Inderpal S. Randhawa, MD

Assistant Professor of Clinical Pediatrics, UC Irvine School of Medicine
Assistant Professor of Medicine, UCLA School of Medicine
Miller Children’s Hospital – Long Beach Memorial

 

randhawa pic (2)

Dr. Inderpal Randhawa is a board-certified in adult medicine and pediatrics. He has additional certifications in Clinical Immunology, Allergy and Pulmonary Medicine. Dr. Randhawa currently serves as the director of the Adult Cystic Fibrosis Center at Long Beach Memorial Hospital. He also serves as the research coordinator for two fellowship programs at the David Geffen UCLA School of Medicine and at UCI-Miller Children’s Hospital. Dr. Randhawa practices clinical medicine in pulmonary diseases, immune deficiencies, allergy and transplant medicine. His clinical interests include severe asthma, food allergy, eosinophilic diseases, bronchiectasis, COPD, cystic fibrosis, intravenous gamma globulin therapy and various immune deficiencies.

Dr. Randhawa received his medical degree from Northwestern University School of Medicine. After completed his postgraduate training in Internal Medicine and Pediatrics at Loma Linda University, he completed training in Clinical Immunology & Allergy at UCLA. He completed his training in pediatric and adult pulmonology at UC Irvine- Miller Children’s Hospital. He received multiple accolades for teaching during his training which reflects his current interest in medical education.
Dr. Randhawa belongs to several professional organizations, including the Immune Deficiency Foundation, American College of Chest Physicians and the American Academy of Allergy, Asthma and Immunology. He is also a fellow of the American College of Allergy, Asthma and Immunology, the American Thoracic Society and the International Society for Heart and Lung Transplantation.

In addition to treating patients and teaching medical students, residents, and fellows, Dr. Randhawa has over 75 publications covering a spectrum of disease in immunology, asthma, allergy and pulmonary disorders. He maintains active research grants in basic science, translational and clinical research arenas. Dr. Randhawa’s novel approach to research science is reflective of his treating the complete age spectrum. Few physicians nationally treat the entire age spectrum within multiple subspecialties. Dr. Randhawa has utilizes this approach particularly in cystic fibrosis, non CF bronchiectasis and other rare lung diseases. Similarly, Dr. Randhawa established the west coast’s first endowed food allergy center. The Gallegos Food Allergy Center is comprehensive center focused on treating and inducing immune tolerance to anaphylaxis foods such as peanuts. Dr. Randhawa has also established a Jeffrey Modell certified immune deficiency center at Miller Children’s Hospital with support from the Immune Deficiency Foundation. Dr. Randhawa’s approach to cystic fibrosis (CF) involves unique insight into exercise physiology, vascular dynamics and the immune system specifically. His approach to CF is based on optimizing standard of care practices in CF. However, once standard of care in CF fails, Dr. Randhawa has focused his “out of the box” approach toward durable patient stabilization and an appropriate bridge to lung transplantation. Dr. Randhawa has demonstrated innovative research and clinical implementation of novel strategies in CF. He has conducted studies on alveolar macrophage immune dysfunction in CF and the effect of air pollution on CF lungs. Alternatively, he has developed novel methods of modifying bronchial artery blood flow to stop airway bleeding in CF. Dr. Randhawa’s clinical immunology background has lead to groundbreaking treatment options for the immune system in CF. Dr. Randhawa maintains the only immunology clinic dedicated to CF nationally.

Dr. Randhawa’s core philosophy is based upon a clear explanation of diagnoses and recommended therapy, involvement of patient in family in all health decisions, and exploring all treatment options including cutting edge therapies. He believes a well researched, well explained, compassionate treatment plan has the greatest chance for the best outcome.